Potential of nanoparticles encapsulated drugs for possible inhibition of the antimicrobial resistance development
The immune system is a dynamic network of cells and cytokines are the major mediators of immune responses which combat pathogens. Based on the cytokine production, effector T cells differentiate into subsets known as Th1, Th2, Th17, or Treg. This system serves as a barrier to intracellular pathogens...
Gespeichert in:
Veröffentlicht in: | Biomedicine & pharmacotherapy 2021-09, Vol.141, p.111943-111943, Article 111943 |
---|---|
Hauptverfasser: | , , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 111943 |
---|---|
container_issue | |
container_start_page | 111943 |
container_title | Biomedicine & pharmacotherapy |
container_volume | 141 |
creator | Pandey, Ramendra Pati Mukherjee, Riya Priyadarshini, Anjali Gupta, Archana Vibhuti, Arpana Leal, Elcio Sengupta, Utpal Katoch, Vishwa Mohan Sharma, Pawan Moore, Catrin E. Raj, V. Samuel Lyu, Xiaoming |
description | The immune system is a dynamic network of cells and cytokines are the major mediators of immune responses which combat pathogens. Based on the cytokine production, effector T cells differentiate into subsets known as Th1, Th2, Th17, or Treg. This system serves as a barrier to intracellular pathogens, bacterial infections and stimulates the production of reactive oxygen species (ROS), reactive nitrogen intermediates, and nitric oxide, which diffuses across membranes and engulfs intracellular pathogens. Oxidative stress occurs when ROS, reactive nitrogen species (RNS) production, and antioxidant defences become imbalanced. Oxidative stress generated by infected cells produces a substantial amount of free radicals which enables the killing of intracellular pathogens. Intracellular pathogens are exposed to endogenous ROS as part of normal aerobic respiration, also exogenous ROS and RNS are generated by the host immune system in response to infection. Nanoparticles which are designed for drug delivery are capable of trapping the desired drug in the particles which protect the drug from enzymatic degradation in a biological system. The subcellular size of nanoparticles enables higher intracellular uptake of the drug which results in the reduction of the concentration of free drugs reducing their toxic effect. Research on the modulation of immune response and oxidative stress using nanoparticles used to encapsulate drugs has yet to be explored fully. In this review, we illustrate the immune activation and generation of oxidative stress properties which are mediated by nanoparticle encapsulated drug delivery systems which can make the therapy more effective in case of diseases caused by intracellular pathogens.
[Display omitted]
•Oxidative stress by infected cells forms free radicals which kills intracellular pathogens.•Oxidative burst a host immune defenses for pathogens to tackle drug resistance.•Chitosan induces immune response against intracellular pathogens.•Nanoparticle drug delivery is for controlled delivery of drugs.•The nano drug delivery system provides site specific actions at optimal level. |
doi_str_mv | 10.1016/j.biopha.2021.111943 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2557232887</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0753332221007253</els_id><sourcerecordid>2557232887</sourcerecordid><originalsourceid>FETCH-LOGICAL-c408t-4394d965fada79635b692782b7c1fd9e1c3c91f6b7466f0e1a6978e901f29003</originalsourceid><addsrcrecordid>eNp9kE1v3CAURVGVqpmk_QdVxDIbT_mwwWwiVVHSVIrULrJHGB4dRrZxAEfKvy8jp1l2xebcex8Hoa-U7Cmh4ttxP4S4HMyeEUb3lFLV8g9oR1VHGkGIPEM7IjvecM7YObrI-UgI6QTvP6Fz3nLWU9Lt0PPvWGAuwYw4ejybOS4mlWBHyBhma5a8jqaAwy6tfzL2MeEl5hyGEXCYD2EIJcT5lC0HwKY2TcGmOJwKE-SQi5ktYAcvMMZlqlOf0Udvxgxf3t5L9HR_93T70Dz--vHz9vtjY1vSl6blqnVKdN44I5Xg3SAUkz0bpKXeKaCWW0W9GGQrhCdAjVCyB0WoZ4oQfomut9olxecVctFTyBbG0cwQ16xZ10lWLfSyou2G1sNzTuD1ksJk0qumRJ9c66PeXOuTa725rrGrt4V1mMC9h_7JrcDNBkD95kuApLMNVSq4kMAW7WL4_8JfOQWTtw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2557232887</pqid></control><display><type>article</type><title>Potential of nanoparticles encapsulated drugs for possible inhibition of the antimicrobial resistance development</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><creator>Pandey, Ramendra Pati ; Mukherjee, Riya ; Priyadarshini, Anjali ; Gupta, Archana ; Vibhuti, Arpana ; Leal, Elcio ; Sengupta, Utpal ; Katoch, Vishwa Mohan ; Sharma, Pawan ; Moore, Catrin E. ; Raj, V. Samuel ; Lyu, Xiaoming</creator><creatorcontrib>Pandey, Ramendra Pati ; Mukherjee, Riya ; Priyadarshini, Anjali ; Gupta, Archana ; Vibhuti, Arpana ; Leal, Elcio ; Sengupta, Utpal ; Katoch, Vishwa Mohan ; Sharma, Pawan ; Moore, Catrin E. ; Raj, V. Samuel ; Lyu, Xiaoming</creatorcontrib><description>The immune system is a dynamic network of cells and cytokines are the major mediators of immune responses which combat pathogens. Based on the cytokine production, effector T cells differentiate into subsets known as Th1, Th2, Th17, or Treg. This system serves as a barrier to intracellular pathogens, bacterial infections and stimulates the production of reactive oxygen species (ROS), reactive nitrogen intermediates, and nitric oxide, which diffuses across membranes and engulfs intracellular pathogens. Oxidative stress occurs when ROS, reactive nitrogen species (RNS) production, and antioxidant defences become imbalanced. Oxidative stress generated by infected cells produces a substantial amount of free radicals which enables the killing of intracellular pathogens. Intracellular pathogens are exposed to endogenous ROS as part of normal aerobic respiration, also exogenous ROS and RNS are generated by the host immune system in response to infection. Nanoparticles which are designed for drug delivery are capable of trapping the desired drug in the particles which protect the drug from enzymatic degradation in a biological system. The subcellular size of nanoparticles enables higher intracellular uptake of the drug which results in the reduction of the concentration of free drugs reducing their toxic effect. Research on the modulation of immune response and oxidative stress using nanoparticles used to encapsulate drugs has yet to be explored fully. In this review, we illustrate the immune activation and generation of oxidative stress properties which are mediated by nanoparticle encapsulated drug delivery systems which can make the therapy more effective in case of diseases caused by intracellular pathogens.
[Display omitted]
•Oxidative stress by infected cells forms free radicals which kills intracellular pathogens.•Oxidative burst a host immune defenses for pathogens to tackle drug resistance.•Chitosan induces immune response against intracellular pathogens.•Nanoparticle drug delivery is for controlled delivery of drugs.•The nano drug delivery system provides site specific actions at optimal level.</description><identifier>ISSN: 0753-3322</identifier><identifier>EISSN: 1950-6007</identifier><identifier>DOI: 10.1016/j.biopha.2021.111943</identifier><identifier>PMID: 34328105</identifier><language>eng</language><publisher>France: Elsevier Masson SAS</publisher><subject>Animals ; Anti-Bacterial Agents - administration & dosage ; Anti-Bacterial Agents - chemical synthesis ; Drug Carriers - administration & dosage ; Drug Carriers - chemical synthesis ; Drug Development - methods ; Drug Development - trends ; Drug Resistance, Bacterial - drug effects ; Drug Resistance, Bacterial - physiology ; Humans ; Immune system ; Intracellular pathogens ; Nanoparticles ; Nanoparticles - administration & dosage ; Nanoparticles - chemistry ; Oxidative stress ; Oxidative Stress - drug effects ; Oxidative Stress - physiology</subject><ispartof>Biomedicine & pharmacotherapy, 2021-09, Vol.141, p.111943-111943, Article 111943</ispartof><rights>2021 The Authors</rights><rights>Copyright © 2021 The Authors. Published by Elsevier Masson SAS.. All rights reserved.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c408t-4394d965fada79635b692782b7c1fd9e1c3c91f6b7466f0e1a6978e901f29003</citedby><cites>FETCH-LOGICAL-c408t-4394d965fada79635b692782b7c1fd9e1c3c91f6b7466f0e1a6978e901f29003</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0753332221007253$$EHTML$$P50$$Gelsevier$$Hfree_for_read</linktohtml><link.rule.ids>314,776,780,3536,27903,27904,65309</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/34328105$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Pandey, Ramendra Pati</creatorcontrib><creatorcontrib>Mukherjee, Riya</creatorcontrib><creatorcontrib>Priyadarshini, Anjali</creatorcontrib><creatorcontrib>Gupta, Archana</creatorcontrib><creatorcontrib>Vibhuti, Arpana</creatorcontrib><creatorcontrib>Leal, Elcio</creatorcontrib><creatorcontrib>Sengupta, Utpal</creatorcontrib><creatorcontrib>Katoch, Vishwa Mohan</creatorcontrib><creatorcontrib>Sharma, Pawan</creatorcontrib><creatorcontrib>Moore, Catrin E.</creatorcontrib><creatorcontrib>Raj, V. Samuel</creatorcontrib><creatorcontrib>Lyu, Xiaoming</creatorcontrib><title>Potential of nanoparticles encapsulated drugs for possible inhibition of the antimicrobial resistance development</title><title>Biomedicine & pharmacotherapy</title><addtitle>Biomed Pharmacother</addtitle><description>The immune system is a dynamic network of cells and cytokines are the major mediators of immune responses which combat pathogens. Based on the cytokine production, effector T cells differentiate into subsets known as Th1, Th2, Th17, or Treg. This system serves as a barrier to intracellular pathogens, bacterial infections and stimulates the production of reactive oxygen species (ROS), reactive nitrogen intermediates, and nitric oxide, which diffuses across membranes and engulfs intracellular pathogens. Oxidative stress occurs when ROS, reactive nitrogen species (RNS) production, and antioxidant defences become imbalanced. Oxidative stress generated by infected cells produces a substantial amount of free radicals which enables the killing of intracellular pathogens. Intracellular pathogens are exposed to endogenous ROS as part of normal aerobic respiration, also exogenous ROS and RNS are generated by the host immune system in response to infection. Nanoparticles which are designed for drug delivery are capable of trapping the desired drug in the particles which protect the drug from enzymatic degradation in a biological system. The subcellular size of nanoparticles enables higher intracellular uptake of the drug which results in the reduction of the concentration of free drugs reducing their toxic effect. Research on the modulation of immune response and oxidative stress using nanoparticles used to encapsulate drugs has yet to be explored fully. In this review, we illustrate the immune activation and generation of oxidative stress properties which are mediated by nanoparticle encapsulated drug delivery systems which can make the therapy more effective in case of diseases caused by intracellular pathogens.
[Display omitted]
•Oxidative stress by infected cells forms free radicals which kills intracellular pathogens.•Oxidative burst a host immune defenses for pathogens to tackle drug resistance.•Chitosan induces immune response against intracellular pathogens.•Nanoparticle drug delivery is for controlled delivery of drugs.•The nano drug delivery system provides site specific actions at optimal level.</description><subject>Animals</subject><subject>Anti-Bacterial Agents - administration & dosage</subject><subject>Anti-Bacterial Agents - chemical synthesis</subject><subject>Drug Carriers - administration & dosage</subject><subject>Drug Carriers - chemical synthesis</subject><subject>Drug Development - methods</subject><subject>Drug Development - trends</subject><subject>Drug Resistance, Bacterial - drug effects</subject><subject>Drug Resistance, Bacterial - physiology</subject><subject>Humans</subject><subject>Immune system</subject><subject>Intracellular pathogens</subject><subject>Nanoparticles</subject><subject>Nanoparticles - administration & dosage</subject><subject>Nanoparticles - chemistry</subject><subject>Oxidative stress</subject><subject>Oxidative Stress - drug effects</subject><subject>Oxidative Stress - physiology</subject><issn>0753-3322</issn><issn>1950-6007</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kE1v3CAURVGVqpmk_QdVxDIbT_mwwWwiVVHSVIrULrJHGB4dRrZxAEfKvy8jp1l2xebcex8Hoa-U7Cmh4ttxP4S4HMyeEUb3lFLV8g9oR1VHGkGIPEM7IjvecM7YObrI-UgI6QTvP6Fz3nLWU9Lt0PPvWGAuwYw4ejybOS4mlWBHyBhma5a8jqaAwy6tfzL2MeEl5hyGEXCYD2EIJcT5lC0HwKY2TcGmOJwKE-SQi5ktYAcvMMZlqlOf0Udvxgxf3t5L9HR_93T70Dz--vHz9vtjY1vSl6blqnVKdN44I5Xg3SAUkz0bpKXeKaCWW0W9GGQrhCdAjVCyB0WoZ4oQfomut9olxecVctFTyBbG0cwQ16xZ10lWLfSyou2G1sNzTuD1ksJk0qumRJ9c66PeXOuTa725rrGrt4V1mMC9h_7JrcDNBkD95kuApLMNVSq4kMAW7WL4_8JfOQWTtw</recordid><startdate>202109</startdate><enddate>202109</enddate><creator>Pandey, Ramendra Pati</creator><creator>Mukherjee, Riya</creator><creator>Priyadarshini, Anjali</creator><creator>Gupta, Archana</creator><creator>Vibhuti, Arpana</creator><creator>Leal, Elcio</creator><creator>Sengupta, Utpal</creator><creator>Katoch, Vishwa Mohan</creator><creator>Sharma, Pawan</creator><creator>Moore, Catrin E.</creator><creator>Raj, V. Samuel</creator><creator>Lyu, Xiaoming</creator><general>Elsevier Masson SAS</general><scope>6I.</scope><scope>AAFTH</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>202109</creationdate><title>Potential of nanoparticles encapsulated drugs for possible inhibition of the antimicrobial resistance development</title><author>Pandey, Ramendra Pati ; Mukherjee, Riya ; Priyadarshini, Anjali ; Gupta, Archana ; Vibhuti, Arpana ; Leal, Elcio ; Sengupta, Utpal ; Katoch, Vishwa Mohan ; Sharma, Pawan ; Moore, Catrin E. ; Raj, V. Samuel ; Lyu, Xiaoming</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c408t-4394d965fada79635b692782b7c1fd9e1c3c91f6b7466f0e1a6978e901f29003</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Animals</topic><topic>Anti-Bacterial Agents - administration & dosage</topic><topic>Anti-Bacterial Agents - chemical synthesis</topic><topic>Drug Carriers - administration & dosage</topic><topic>Drug Carriers - chemical synthesis</topic><topic>Drug Development - methods</topic><topic>Drug Development - trends</topic><topic>Drug Resistance, Bacterial - drug effects</topic><topic>Drug Resistance, Bacterial - physiology</topic><topic>Humans</topic><topic>Immune system</topic><topic>Intracellular pathogens</topic><topic>Nanoparticles</topic><topic>Nanoparticles - administration & dosage</topic><topic>Nanoparticles - chemistry</topic><topic>Oxidative stress</topic><topic>Oxidative Stress - drug effects</topic><topic>Oxidative Stress - physiology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Pandey, Ramendra Pati</creatorcontrib><creatorcontrib>Mukherjee, Riya</creatorcontrib><creatorcontrib>Priyadarshini, Anjali</creatorcontrib><creatorcontrib>Gupta, Archana</creatorcontrib><creatorcontrib>Vibhuti, Arpana</creatorcontrib><creatorcontrib>Leal, Elcio</creatorcontrib><creatorcontrib>Sengupta, Utpal</creatorcontrib><creatorcontrib>Katoch, Vishwa Mohan</creatorcontrib><creatorcontrib>Sharma, Pawan</creatorcontrib><creatorcontrib>Moore, Catrin E.</creatorcontrib><creatorcontrib>Raj, V. Samuel</creatorcontrib><creatorcontrib>Lyu, Xiaoming</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Biomedicine & pharmacotherapy</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Pandey, Ramendra Pati</au><au>Mukherjee, Riya</au><au>Priyadarshini, Anjali</au><au>Gupta, Archana</au><au>Vibhuti, Arpana</au><au>Leal, Elcio</au><au>Sengupta, Utpal</au><au>Katoch, Vishwa Mohan</au><au>Sharma, Pawan</au><au>Moore, Catrin E.</au><au>Raj, V. Samuel</au><au>Lyu, Xiaoming</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Potential of nanoparticles encapsulated drugs for possible inhibition of the antimicrobial resistance development</atitle><jtitle>Biomedicine & pharmacotherapy</jtitle><addtitle>Biomed Pharmacother</addtitle><date>2021-09</date><risdate>2021</risdate><volume>141</volume><spage>111943</spage><epage>111943</epage><pages>111943-111943</pages><artnum>111943</artnum><issn>0753-3322</issn><eissn>1950-6007</eissn><abstract>The immune system is a dynamic network of cells and cytokines are the major mediators of immune responses which combat pathogens. Based on the cytokine production, effector T cells differentiate into subsets known as Th1, Th2, Th17, or Treg. This system serves as a barrier to intracellular pathogens, bacterial infections and stimulates the production of reactive oxygen species (ROS), reactive nitrogen intermediates, and nitric oxide, which diffuses across membranes and engulfs intracellular pathogens. Oxidative stress occurs when ROS, reactive nitrogen species (RNS) production, and antioxidant defences become imbalanced. Oxidative stress generated by infected cells produces a substantial amount of free radicals which enables the killing of intracellular pathogens. Intracellular pathogens are exposed to endogenous ROS as part of normal aerobic respiration, also exogenous ROS and RNS are generated by the host immune system in response to infection. Nanoparticles which are designed for drug delivery are capable of trapping the desired drug in the particles which protect the drug from enzymatic degradation in a biological system. The subcellular size of nanoparticles enables higher intracellular uptake of the drug which results in the reduction of the concentration of free drugs reducing their toxic effect. Research on the modulation of immune response and oxidative stress using nanoparticles used to encapsulate drugs has yet to be explored fully. In this review, we illustrate the immune activation and generation of oxidative stress properties which are mediated by nanoparticle encapsulated drug delivery systems which can make the therapy more effective in case of diseases caused by intracellular pathogens.
[Display omitted]
•Oxidative stress by infected cells forms free radicals which kills intracellular pathogens.•Oxidative burst a host immune defenses for pathogens to tackle drug resistance.•Chitosan induces immune response against intracellular pathogens.•Nanoparticle drug delivery is for controlled delivery of drugs.•The nano drug delivery system provides site specific actions at optimal level.</abstract><cop>France</cop><pub>Elsevier Masson SAS</pub><pmid>34328105</pmid><doi>10.1016/j.biopha.2021.111943</doi><tpages>1</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0753-3322 |
ispartof | Biomedicine & pharmacotherapy, 2021-09, Vol.141, p.111943-111943, Article 111943 |
issn | 0753-3322 1950-6007 |
language | eng |
recordid | cdi_proquest_miscellaneous_2557232887 |
source | MEDLINE; Elsevier ScienceDirect Journals; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals |
subjects | Animals Anti-Bacterial Agents - administration & dosage Anti-Bacterial Agents - chemical synthesis Drug Carriers - administration & dosage Drug Carriers - chemical synthesis Drug Development - methods Drug Development - trends Drug Resistance, Bacterial - drug effects Drug Resistance, Bacterial - physiology Humans Immune system Intracellular pathogens Nanoparticles Nanoparticles - administration & dosage Nanoparticles - chemistry Oxidative stress Oxidative Stress - drug effects Oxidative Stress - physiology |
title | Potential of nanoparticles encapsulated drugs for possible inhibition of the antimicrobial resistance development |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-25T20%3A15%3A34IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Potential%20of%20nanoparticles%20encapsulated%20drugs%20for%20possible%20inhibition%20of%20the%20antimicrobial%20resistance%20development&rft.jtitle=Biomedicine%20&%20pharmacotherapy&rft.au=Pandey,%20Ramendra%20Pati&rft.date=2021-09&rft.volume=141&rft.spage=111943&rft.epage=111943&rft.pages=111943-111943&rft.artnum=111943&rft.issn=0753-3322&rft.eissn=1950-6007&rft_id=info:doi/10.1016/j.biopha.2021.111943&rft_dat=%3Cproquest_cross%3E2557232887%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2557232887&rft_id=info:pmid/34328105&rft_els_id=S0753332221007253&rfr_iscdi=true |